HAMLET BIOPHARMA

Hamlet BioPharma is the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections. Hamlet BioPharma has now completed Phase II clinical trials and successfully treated patients with three different diseases... Hamlet BioPharma is therefore continuing the clinical programme with a controlled phase II study in this patient group. The study was initiated with a screening phase, to identify patients who responded to treatment. A significant proportion of patients treated with anakinra responded favorably to treatment.

Also known as: Hamlet Biopharma AB, Hamlet BioPharma AB (publ)

Registration numbers: 556568-8958 (W)

Primary location: Lund Sweden